Two pathways have emerged as drivers of the progressive vascular remodeling observed in PAH: the platelet-derived growth factor receptor (PDGFR) and the transforming growth factor β (TGFβ) superfamily. The gene discussed is TGFB1; the disease is pulmonary arterial hypertension.